AstraZeneca COVID-19 Vaccine Linked To Another Fatal, Rare Blood Disorder; Details Here
Adenovirus-based vaccines made by AstraZeneca, which was recently pulled out of the market, contains a component that can trigger blood clots in genetically susceptible individuals, Australian scientists have reported in the medical journal New England Journal of Medicine.